Pharmaceutical Division
Danicopan
Danicopan is used for the treatment of Paroxysmal Nocturnal Hemoglobinuria.
Under developmentParoxysmal Nocturnal Hemoglobinuria (PNH)CAS 1391668-29-9
Quality Assured
Complement inhibitor
Under development
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Danicopan – CAS 1391668-29-9
CAS Number
1391668-29-9
Category
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Therapeutic Class
Complement inhibitor
Description
Danicopan is used for the treatment of Paroxysmal Nocturnal Hemoglobinuria.
Applications
- PNH treatment
- Complement system inhibition
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.